The DZIF Accelerates the Fight against Antibiotic-Resistant Bacteria

Publié sur DZIF - German Center for Infection Research, le 27/02/2019

Recherche & Développement

Tags : DZIF - German Center for infection Research, Allemagne, antibiotique, CARB-X, santé, biotechnologies, industrie pharmaceutique, US National Institutes of Health, Wellcome Trust Sanger Institute, US Biomedical Advanced Research and Development Authority, Bill & Melinda Gates Foundation, financement de la recherche